180 related articles for article (PubMed ID: 28849249)
1. Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer.
Strohkamp S; Gemoll T; Humborg S; Hartwig S; Lehr S; Freitag-Wolf S; Becker S; Franzén B; Pries R; Wollenberg B; Roblick UJ; Bruch HP; Keck T; Auer G; Habermann JK
Cell Mol Life Sci; 2018 Jan; 75(2):323-334. PubMed ID: 28849249
[TBL] [Abstract][Full Text] [Related]
2. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
3. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
4. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
6. Clusterin in stool: a new biomarker for colon cancer screening?
Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
[TBL] [Abstract][Full Text] [Related]
7. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
8. Exploration of the platelet proteome in patients with early-stage cancer.
Sabrkhany S; Kuijpers MJE; Knol JC; Olde Damink SWM; Dingemans AC; Verheul HM; Piersma SR; Pham TV; Griffioen AW; Oude Egbrink MGA; Jimenez CR
J Proteomics; 2018 Apr; 177():65-74. PubMed ID: 29432918
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
10. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
11. High clusterin expression correlates with a poor outcome in stage II colorectal cancers.
Kevans D; Foley J; Tenniswood M; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):393-9. PubMed ID: 19155441
[TBL] [Abstract][Full Text] [Related]
12. Differences in the resting platelet proteome and platelet releasate between healthy children and adults.
Cini C; Yip C; Attard C; Karlaftis V; Monagle P; Linden M; Ignjatovic V
J Proteomics; 2015 Jun; 123():78-88. PubMed ID: 25868662
[TBL] [Abstract][Full Text] [Related]
13. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
14. Effects of Cancer Presence and Therapy on the Platelet Proteome.
Walraven M; Sabrkhany S; Knol JC; Dekker H; de Reus I; Piersma SR; Pham TV; Griffioen AW; Broxterman HJ; Oude Egbrink M; Verheul HMW; Jimenez CR
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361002
[TBL] [Abstract][Full Text] [Related]
15. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.
Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A
Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651
[TBL] [Abstract][Full Text] [Related]
16. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
17. Secreted clusterin in colon tumor cell models and its potential as diagnostic marker for colorectal cancer.
Rodríguez-Piñeiro AM; García-Lorenzo A; Blanco-Prieto S; Alvarez-Chaver P; Rodríguez-Berrocal FJ; Cadena MP; Martínez-Zorzano VS
Cancer Invest; 2012 Jan; 30(1):72-8. PubMed ID: 22236192
[TBL] [Abstract][Full Text] [Related]
18. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway.
Radziwon-Balicka A; Santos-Martinez MJ; Corbalan JJ; O'Sullivan S; Treumann A; Gilmer JF; Radomski MW; Medina C
Carcinogenesis; 2014 Feb; 35(2):324-32. PubMed ID: 24085798
[TBL] [Abstract][Full Text] [Related]
20. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
